🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 02155X106 (prev. 739727204 )
- Market Cap
- Micro Cap
- ADR Ratio
- 1:60
- Previous Symbol
- PRAN (changed 4/8/2019)
- Previous Name
- Prana Biotechnology Ltd.
Business: Alterity Therapeutics Ltd. is an Australia-based development stage medical biotechnology Company. The Company is engaged in commercializing research into Alzheimer's disease, Huntington disease and other major age-related degenerative disorders with the lead drug candidate, PBT2. Alterity also has advanced a drug candidate for Parkinson’s disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Notes: March 24, 2016 -- Prana Biotechnology Ltd (PRAN) will effect a one for six (1-6) reverse split of its outstanding American Depositary Shares (ADS), and a ratio change of the ADS from one ADS representing ten Ordinary Shares to one ADS representing 60 Ordinary Shares. The changes will become effective today. In conjunction with the reverse split, the CUSIP number will change to 739727204.
Company Contact
- CEO
- David Stamler
- CFO
- Kathryn Andrews
- Investor Relations
- rwilson@we-buchan.com